Irritable Mood Clinical Trials
2 recruiting trials for Irritable Mood. Eligibility criteria explained in plain English.
TrialFinderData lists 2 Irritable Mood clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Research is led by Walter Reed National Military Medical Center (1), Oregon Health and Science University (1), among the most active sponsors registered for these trials.
The most frequently studied intervention is Art Therapy (behavioral, 1 trial), followed by Multinutrients; a 36-ingredient blend of vitamins, minerals, amino acids, and antioxidants.
Track Irritable Mood trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
Art Therapy and Emotional Well Being in Military Populations With Posttraumatic Stress Symptoms
Art therapy is used across the Military Health System for treatment of posttraumatic symptoms, but there is limited research on how art therapy is able to restore emotional...
Optimizing Research With Diverse Families - Feasibility and Acceptability Study (FAST)
Evaluate feasibility and acceptability of recruiting Black and Hispanic families for an open label clinical trial of multinutrients while collecting real-time parent-reported...
Explore Other Conditions
Frequently Asked Questions
There are currently 2 clinical trials for Irritable Mood, with 2 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for Irritable Mood, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Irritable Mood, representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.